Rome BN, Garrett KR, Maini L - JAMA Network Open
When comparing the Coverage Gap Discount (CGD) and the Manufacturer Discount Program (MDP) in Medicare Part D, Medicare would have received $34 billion from drug makers under the MDP, compared to $17 billion under the CGD based on 2022 data. Discounts in the MDP also increased substantially for high-cost specialty drugs, highlighting how this policy change will affect Medicare Part D spending going forward.
VIEW SOURCE
Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics
Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine
Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open